LAB International Initiates Patient Enrollment in the Extension of Its Phase IIb Fentanyl TAIFUN(R) Trial (RedNova)

MONTREAL, Jan. 31 /PRNewswire-FirstCall/ -- LAB International Inc.

[News Source]